Marshall Urist sold $508K of RPRX stock

Marshall Urist, EVP, Research & Investments of Royalty Pharma plc (RPRX), sold 9,099 shares of RPRX stock worth $508K, per an SEC Form 4 filed Jul 2, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade happened on Jul 1, 2026, 1 day before it was made public.

RPRX has moved +23.6% since the trade date, from $55.78 to $68.97 (Nov 12, 2026 close).